首页 | 本学科首页   官方微博 | 高级检索  
     

低分子量肝素对缺血性心脏病凝血机制的影响
引用本文:汪洪毅,孙伟,崔中光,朱海青. 低分子量肝素对缺血性心脏病凝血机制的影响[J]. 中国药房, 2004, 15(5): 296-297
作者姓名:汪洪毅  孙伟  崔中光  朱海青
作者单位:青岛大学医学院附属医院,青岛市,266003
摘    要:目的 :研究低分子量肝素对缺血性心脏病患者高凝状态的影响。方法 :观察75例缺血性心脏病患者应用低分子量肝素后 ,凝血和抗凝血机制的变化。结果 :抗凝血酶Ⅲ活性在用药前为 (0 871±0 065)IU ,用药后10h为 (1 113±1 013)IU (t=3 22 ,P<0 05) ,有显著性差异 ;组织型纤溶酶原激活酶活性在用药前、后则分别为 (1 50±0 22)、(2 31±1 02)IU (t=8 45 ,P<0 01) ,有极显著性差异。结论 :低分子量肝素不但可改善缺血性心脏病患者高凝状态 ,且没有出血倾向。

关 键 词:低分子量肝素  缺血性心脏病  凝血机制
文章编号:1001-0408(2004)05-0296-02
修稿时间:2003-12-24

Effect of Low Molecular Weight Heparin on Coagulation Mechanism in Ischemic Heart Disease
WANG Hongyi,SUN Wei,CUI Zhongguang,ZHU HaiqingThe Affiliated Hospital of Medical College,Qingdao University,Qingdao. Effect of Low Molecular Weight Heparin on Coagulation Mechanism in Ischemic Heart Disease[J]. China Pharmacy, 2004, 15(5): 296-297
Authors:WANG Hongyi  SUN Wei  CUI Zhongguang  ZHU HaiqingThe Affiliated Hospital of Medical College  Qingdao University  Qingdao
Affiliation:WANG Hongyi,SUN Wei,CUI Zhongguang,ZHU HaiqingThe Affiliated Hospital of Medical College,Qingdao University,Qingdao266003
Abstract:OBJECTIVE:To study the effect of low molecular weight heparinLMWHon hypercoagulability in patients with ischemic heart diseaseIHD.METHODS:The coagulation and anticoagulation functions after using LMWH were obˉserved in75patients with IHD.RESULTS:The activities of antithrombinⅢand t-PA were0.871±0.065IU and1.50±0.22IU before administration of drug,and1.113±1.013IUP<0.05and2.31±1.02IUP<0.0110h after adminisˉtration,respectively.CONCLUSION:The administration of LMWH can ameliorate the hypercoagulability of patients with IHD without the tendency of hemorrhage.
Keywords:low molecular weight heparin  ischemic heart disease  coagulation mechanism
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号